Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05446467
Status:
RECRUITING
Last Update Posted:
2024-03-26
First Post:
2022-06-30
Brief Title:
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Sponsor:
Zhejiang Provincial Peoples Hospital
Organization:
Zhejiang Provincial Peoples Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-30
First Submit QC Date:
June 30 2022
Study First Post Date:
2022-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-25
Last Update Post Date:
2024-03-26
Last Update Post Date Type:
ACTUAL